Beone gets NOD FDA to version of Zanubrutinib tablet (onc)

Beone Medical (Nasdak:ONCHe said on Wednesday that she had obtained approval from the US Food and Drug Administration to obtain a new disk version of her drug, Zanubrutinib, a small molecule that prevents the turquoise Kenaz Proton.

This approval covers all the five current indicators